Why the study?
Although minimally invasive cardiac surgery via right anterolateral thoracotomy is proven to have lower postoperative complications, the comparative neurological complications, postoperative outcomes, and survival up to 5 years between elderly and younger patients were evaluated.
Does minimally invasive cardiac valve surgery with retrograde femoral arterial perfusion increase postoperative complications in patients ≥70 years old compared to those <70 years old?
Does minimally invasive cardiac valve surgery with retrograde femoral arterial perfusion increase postoperative complications in patients ≥70 years old compared to those <70 years old?
Retrograde femoral arterial perfusion during minimally invasive cardiac valve surgery is safe in elderly patients (≥70 years), with comparable neurological and survival outcomes to younger patients.
Answers are grounded in this paper and cite their sources.
Supports offering retrograde femoral perfusion in elderly patients for minimally invasive valve surgery; leaves open need for randomized confirmation of neurological safety.
(1) Background: Minimal invasive cardiac surgery via right anterolateral thoracotomy for heart valve surgery and other intracardiac procedures proven to have lower postoperative complications. We aim to compare the neurological complications and post-operative outcomes in two cohort groups as well as survival rates up to 5 years postoperatively; (2) Methodology: Retrospective observational study for patients who had minimally invasive cardiac valve surgery with retrograde femoral arterial perfusion between 2007 and 2021 (n = 596) and the categorized patients into two groups based on their age (≥70 years old and below 70). Propensity match analysis was conducted. The primary endpoint consisted of major postoperative complications and the secondary endpoint was the long-term survival rate. (3) Results: There was no difference between the two groups in terms of postoperative outcomes. Patients ≥ 70 years old had no increased risk for neurological complications (p = 0.75) compared with those below 70 years old. The mortality rate was also not significant between the two groups (p = 0.37) as well as the crude survival rates. (4) Conclusions: The use of retrograde femoral arterial perfusion in elderly patients is not associated with increased risk compared to the younger patients’ group for a spectrum of primary cardiac valve procedures. Hence, minimally invasive approaches could be offered to elderly patients who might benefit from it.
No takes yet. Share an insight, caveat, or question.
Elhassan et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: